Hercules Technology Growth Capital, Inc. (HTGC) - 2012 10-K Summary
Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2012
Business Model: HTGC is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). It focuses on providing senior secured loans, structured debt with warrants, and equity investments to venture capital-backed companies in technology-related markets (technology, biotechnology, life science, and clean technology).
Operations: The company operates through its principal office in Palo Alto, CA, and subsidiaries including two Small Business Investment Companies (SBICs): Hercules Technology II, L.P. (HT II) and Hercules Technology III, L.P. (HT III).
Key Financial Metrics
| Metric | 2012 | 2011 |
|---|---|---|
| Total Assets | $1,123.6 million | $747.4 million |
| Total Investments (at value) | $906.3 million | $652.9 million |
| Total Liabilities | $607.7 million | $316.4 million |
| Total Net Assets | $516.0 million | $431.0 million |
| Net Asset Value (NAV) per Share | $9.75 | $9.83 |
| Total Investment Income | $97.5 million | $79.9 million |
| Net Investment Income | $48.1 million | $39.6 million |
| Net Realized Gain | $3.2 million | $2.7 million |
| Net Unrealized Depreciation | ($4.5 million) | $4.6 million (Appreciation) |
| Net Increase in Net Assets from Operations | $46.8 million | $46.9 million |
| Cash and Cash Equivalents | $183.0 million | $64.5 million |
| Dividends Declared per Share | $0.95 | $0.88 |
Material Changes vs. Prior Period
- Portfolio Growth: Total investment portfolio value increased 38.8% to $906.3 million, driven by $469.9 million in new fundings. The loan portfolio grew to $827.5 million.
- Debt Structure: Total indebtedness increased significantly due to the issuance of $170.4 million in 2019 Notes and $129.3 million in Asset-Backed Notes (via a debt securitization). Conversely, borrowings under the Wells Facility were fully repaid, leaving $0 outstanding at year-end.
- Income: Net investment income rose 21.5% to $48.1 million, primarily due to a larger average investment portfolio. Interest income increased to $87.6 million.
- Unrealized Gains/Losses: Unlike 2011, which saw $4.6 million in unrealized appreciation, 2012 recorded $4.5 million in net unrealized depreciation, largely attributed to market/yield adjustments and collateral-based impairments.
- Liquidity: Cash and cash equivalents more than doubled to $183.0 million, supported by equity offerings ($81.6 million in proceeds) and debt issuances.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Management expects to continue investing in structured debt with warrants and equity in technology-related markets.
- The company maintains a variable dividend policy targeting 90-100% of taxable quarterly income. On February 26, 2013, the Board increased the quarterly dividend to $0.25 per share.
- As of February 25, 2013, the company had $115.6 million in closed commitments and $126.5 million in pending commitments.
Risks and Contingencies:
- Concentration Risk: The portfolio is concentrated in specific sectors; the top five industries (Drug Discovery, Internet Services, Clean Tech, Drug Delivery, Software) comprised 65.8% of the portfolio. The top 10 portfolio companies represented 35.2% of total fair value.
- Leverage: The company utilizes significant leverage. Total leverage (including SBA debentures) was 185.4% at year-end. Regulatory asset coverage (excluding SBA) was 296.8%.
- Valuation Uncertainty: Approximately 80.7% of assets are Level 3 investments (private companies) valued by the Board of Directors, subject to inherent uncertainty.
- Interest Rate Risk: 98.5% of the loan portfolio is at floating rates. While this benefits from rising rates, it increases portfolio company default risk if rates rise significantly.
- Securitization Risk: The Asset-Backed Notes transaction introduces risks related to rapid amortization events and potential misalignment of interests with noteholders.
Key Facts for Investor Verification
- Dividend Sustainability: Verify if the company can maintain its dividend payout ratio given the increase in interest expense from new debt issuances (2019 Notes and Asset-Backed Notes).
- Portfolio Quality: Monitor the weighted average investment grading (2.06 at year-end) and the percentage of loans in Grade 3, 4, or 5 status, which increased slightly compared to 2011.
- Capital Deployment: Track the funding of the $61.9 million in unfunded contractual commitments and the $126.5 million in pending term sheets to ensure capital is deployed efficiently.
- NAV vs. Market Price: Compare the reported NAV per share ($9.75) with the trading price to assess potential dilution risks if the company issues shares below NAV (authorized up to 20% by shareholders).
- SBA Compliance: Confirm continued compliance with SBA regulations for HT II and HT III, as non-compliance could restrict distributions needed to maintain RIC tax status.